Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Management for specific patient populations, along with links to other COVID-19 related guidelines, are provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics", section on 'Society guideline topics by medical specialty'.)

International

●World Health Organization (WHO): Therapeutics and COVID-19 – Living guideline (2022)

●WHO: Living guidance for clinical management of COVID-19 (2021)

●Endocrine Society (ES): A statement on dexamethasone and COVID-19 (2020)

●WHO: Corticosteroids for COVID-19 – Living guidance (2020)

●WHO: Home care for patients with suspected or confirmed COVID-19 and management of their contacts – Interim guidance (2020)

●WHO: Use of chest imaging in COVID-19 – A rapid advice guide (2020)

Canada

●Updated guidance on use and prioritization of monoclonal antibody therapy for treatment of COVID-19 in adolescents (2022)

●Canadian Paediatric Society (CPS): Position statement on the acute management of COVID-19 in paediatrics (2020, updated 2021)

●Public Health Agency of Canada (PHAC): COVID-19 signs, symptoms and severity of disease – A clinician guide (2021)

●PHAC: National case definition – Coronavirus disease (COVID-19) (2021)

●Canadian Society of Thoracic Radiology (CSTR) and the Canadian Association of Radiologists (CAR): Statement on COVID-19 (2020)

●Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2 (2020)

United States

●Centers for Disease Control and Prevention (CDC): Clinical care quick reference for COVID-19 (2022)

●Infectious Diseases Society of America (IDSA): Guidelines on the treatment and management of patients with COVID-19 (2020, updated 2022)

●National Institutes of Health (NIH): COVID-19 treatment guidelines (2022)

•Anti-SARS-CoV-2 antibody products

•Antiviral therapy

•Cell-based therapy under evaluation for the treatment of COVID-19

•Clinical management

•Clinical spectrum of SARS-CoV-2 infection

•Considerations for certain concomitant medications in patients with COVID-19

•Immunomodulators

•Interim statement on patient prioritization for outpatient anti-SARS-CoV-2 therapies or preventive strategies when there are logistical or supply constraints

•Overview of COVID-19

•Statement on potential drug-drug interactions between ritonavir-boosted nirmatrelvir (paxlovid) and concomitant medications

•Statement on therapies for high-risk, nonhospitalized patients with mild to moderate COVID-19

•Supplements

●Updated guidance on use and prioritization of monoclonal antibody therapy for treatment of COVID-19 in adolescents (2022)

●CDC: Evaluating and caring for patients with post-COVID conditions – Interim guidance (2021)

●CDC: Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19) (2021)

●CDC: Underlying medical conditions associated with high risk for severe COVID-19 – Information for healthcare providers (2021)

●American College of Radiology (ACR): Recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection (2020)

●American Thoracic Society (ATS)/European Respiratory Society (ERS): Updated guidance on the management of COVID-19 (2020)

●Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2 (2020)

Europe

●European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Rapid guidelines for assessment and management of long COVID (2022)

●American Thoracic Society (ATS)/European Respiratory Society (ERS): Updated guidance on the management of COVID-19 (2020)

●European Centre for Disease Prevention and Control (ECDC): Case definition for coronavirus disease 2019 (COVID-19) (2020)

●European Society for Paediatric Radiology (ESPR): Practical recommendations for management strategies for children with COVID-19 (2020)

United Kingdom

●National Health Service (NHS) England: Interim clinical commissioning policy – Neutralising monoclonal antibodies and intravenous antivirals in the treatment of COVID-19 in hospitalised patients (2021, updated 2022)

●NHS: Interim clinical commissioning policy – Neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 (2021, updated 2022)

●National Institute for Health and Care Excellence (NICE): COVID-19 rapid guideline – Managing COVID-19 (2021, updated 2022)

●NHS England: Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19 – Guidance (2020, updated 2021)

●NHS England: COVID-19 therapy – Corticosteroids including dexamethasone and hydrocortisone (2020, updated 2021)

●NICE: COVID-19 rapid guideline – Managing the long-term effects of COVID-19 (2020, updated 2021)

●Public Health England (PHE): Guidance on COVID-19 – Investigation and management of suspected SARS-CoV-2 reinfections (2021)

●PHE: Guidance on COVID-19 – Long-term health effects (2020, updated 2021)

●Scottish Intercollegiate Guidelines Network (SIGN): Guideline on managing the long-term effects of COVID-19 (2020, updated 2021)

●British Society of Thoracic Imaging (BSTI): Thoracic imaging in COVID-19 infection – Guidance for the reporting radiologist (2020)

●Diabetes UK, Joint British Diabetes Societies (JBDS), and Association of British Clinical Diabetologists (ABCD): Concise advice on Inpatient Diabetes (COVID: Diabetes) – Dexamethasone/glucocorticosteroid therapy in COVID-19 patients: Implications and guidance for the management of blood glucose in people with and without diabetes (2020)

●Public Health England (PHE): Guidance on COVID-19 – Investigation and initial clinical management of possible cases (2020)

India

●All India Institute of Medical Science (AIIMS)/Indian Council of Medical Research (ICMR): Clinical guidance for management of adult COVID-19 patients (2022)

●Ministry of Health & Family Welfare (MHFW): Revised comprehensive guidelines for management of COVID-19 in children and adolescents (below 18 years) (2022)

●Ministry of Health & Family Welfare (MHFW): Revised discharge policy for COVID-19 (2022)

●MHFW: Clinical management protocol for COVID-19 (in adults) (2021)

●MHFW: National comprehensive guidelines for management of post-COVID sequelae (2021)

●Indian Council of Medical Research (ICMR): Revised advisory on the use of hydroxychloroquine (HCQ) as prophylaxis for SARS-CoV-2 infection (2020)

●MHFW: Post COVID management protocol (2020)

Australia–New Zealand

●National COVID-19 Clinical Evidence Taskforce: Living guidelines on caring for people with COVID-19 (2022)

●New South Wales (NSW) Health: Care of adults and children in the community with COVID-19 – Standard clinical assessment and risk of deterioration assessment (2022)

●NSW Health: Caring for adults and children in the community with COVID-19 (RAT and PCR positive) – Flow chart and care protocols (2022)

●NSW Health: Care of adult patients with COVID-19 in acute inpatient wards (2021)

●NSW Health: Interim guidance on use of antiviral and immunomodulation therapy in COVID-19 (2021)

●NSW Health: Management of adults with COVID-19 in the post-acute phase – A model of care for NSW health clinicians (2021)

Japan

●[In Japanese] Choosing Wisely Japan: Do not prescribe unproven therapeutic agents to COVID-19 patients except in approved clinical trials (2020)

●[In Japanese] Japan Pediatric Society (JPS), Japan Pediatric Infectious Diseases Society (JPIDS), Japan Outpatient Pediatric Society: Coronavirus infection 2019 (COVID-19) medical treatment guidelines in pediatric outpatient clinics (2020)

●[In Japanese] National Institute of Infectious Diseases (NIID): New coronavirus infectious disease, health and infection control at home treatment (2020)

Resources for patients — The following links provide resources about COVID-19 for non-clinicians. These resources come from select society and government-sponsored guidelines from several countries and regions around the world.

●[International] World Health Organization (WHO): Coronavirus disease (COVID-19) – Home care for families and caregivers

●[United States] Centers for Disease Control and Prevention (CDC): If you are sick or caring for someone

●[United Kingdom] National Health Service (NHS): How to look after yourself at home if you have coronavirus (COVID-19)

●[United Kingdom] NHS: Long-term effects of coronavirus (long COVID)

UpToDate also offers "The Basics" patient education pieces, which are written by the doctors and editors at UpToDate. These are written in plain language, at the 5^th to 6^th grade reading level, and answer the main questions a person is likely to have. (See "Patient education: COVID-19 overview (The Basics)" and "Patient education: COVID-19 and children (The Basics)" and "Patient education: COVID-19 and pregnancy (The Basics)" and "Patient education: COVID-19 vaccines (The Basics)".)